These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 86506)
1. Immune responses in mice infected with lactic dehydrogenase virus. IV. Functional status of the macrophage during acute LDV infection. Michaelides MC; Simms ES Immunology; 1979 Feb; 36(2):241-6. PubMed ID: 86506 [TBL] [Abstract][Full Text] [Related]
2. Immune responses in mice infected with lactic dehydrogenase virus. I. Antibody response to DNP-BGG and hyperglobulinaemia in BALB/c mice. Michaelides MC; Simms ES Immunology; 1977 Jun; 32(6):981-8. PubMed ID: 885591 [TBL] [Abstract][Full Text] [Related]
3. Lactic dehydrogenase virus (LDV) impairs the antigen-presenting capacity of macrophages yet fails to affect their phagocytic activity. Isakov N; Feldman M; Segal S Immunobiology; 1982; 162(1):15-27. PubMed ID: 7106838 [TBL] [Abstract][Full Text] [Related]
4. Lactic dehydrogenase virus infection prevents development of anti-nuclear antibody in (NZB x NZW)F1 mice; role of prostaglandin E2 and macrophage Ia antigen expression. Hayashi T; Mori I; Yamamoto H Int J Exp Pathol; 1992 Oct; 73(5):593-601. PubMed ID: 1419777 [TBL] [Abstract][Full Text] [Related]
5. Transplacental lactate dehydrogenase-elevating virus (LDV) transmission: immune inhibition of umbilical cord infection, and correlation of fetal virus susceptibility with development of F4/80 antigen expression. Zitterkopf NL; Haven TR; Huela M; Bradley DS; Cafruny WA Placenta; 2002 May; 23(5):438-46. PubMed ID: 12061860 [TBL] [Abstract][Full Text] [Related]
6. Nitric oxide production by splenic macrophages is not responsible for T cell suppression during acute infection with lactate dehydrogenase-elevating virus. Rowland RR; Butz EA; Plagemann PG J Immunol; 1994 Jun; 152(12):5785-95. PubMed ID: 8207208 [TBL] [Abstract][Full Text] [Related]
7. Neonatal infection of mice with lactate dehydrogenase-elevating virus results in suppression of humoral antiviral immune response but does not alter the course of viraemia or the polyclonal activation of B cells and immune complex formation. Rowland RR; Even C; Anderson GW; Chen Z; Hu B; Plagemann PG J Gen Virol; 1994 May; 75 ( Pt 5)():1071-81. PubMed ID: 8176369 [TBL] [Abstract][Full Text] [Related]
8. Blocking of cell-mediated immunity to Moloney murine sarcoma virus-transformed cells by lactate dehydrogenase virus-antibody complex. McDonald TL J Natl Cancer Inst; 1983 Mar; 70(3):493-7. PubMed ID: 6572738 [TBL] [Abstract][Full Text] [Related]
9. Detection of the binding of IgG2a and IgG2b on the surface of macrophages from mice chronically infected with lactic dehydrogenase virus. Hayashi T; Onodera T; Yamamoto H J Comp Pathol; 1992 Jul; 107(1):35-40. PubMed ID: 1430346 [TBL] [Abstract][Full Text] [Related]
10. Immunoglobulin transfer from immune-reconstituted SCID mice to nursing neonates: blood distribution of antibody and association with perinatal virus protection. Broen JJ; Cafruny WA Reg Immunol; 1993; 5(1):44-52. PubMed ID: 8347469 [TBL] [Abstract][Full Text] [Related]
11. A tumor-associated lactic dehydrogenase virus suppresses the host resistance to infection with Listeria monocytogenes. Isakov N; Segal S Immunobiology; 1983 May; 164(5):402-16. PubMed ID: 6873999 [TBL] [Abstract][Full Text] [Related]
12. Effect of lactic dehydrogenase virus infection on tumor induction and tumor growth. Isakov N; Feldman M; Segal S Cancer Res; 1981 Feb; 41(2):667-72. PubMed ID: 7448812 [TBL] [Abstract][Full Text] [Related]
13. Immune responses in mice infected with lactic dehydrogenase virus. III. Antibody response to a T-dependent and a T-independent antigen during acute and chronic LDV infection. Michaelides MC; Simms ES Cell Immunol; 1980 Mar; 50(2):253-60. PubMed ID: 6986993 [No Abstract] [Full Text] [Related]
14. Acute infection of mice with lactate dehydrogenase-elevating virus enhances Fc and complement receptor activity of peritoneal macrophages. Lussenhop N; Holmes B; Cafruny WA; Plagemann PG J Gen Virol; 1982 Jul; 61 (Pt l)():25-32. PubMed ID: 7119750 [TBL] [Abstract][Full Text] [Related]
15. Enhanced clearance of lactic dehydrogenase-5 in severe combined immunodeficiency (SCID) mice: effect of lactic dehydrogenase virus on enzyme clearance. Hayashi T; Ozaki M; Mori I; Saito M; Itoh T; Yamamoto H Int J Exp Pathol; 1992 Apr; 73(2):173-81. PubMed ID: 1571277 [TBL] [Abstract][Full Text] [Related]
16. Lactate dehydrogenase-elevating virus (LDV): lifelong coexistence of virus and LDV-specific immunity. van den Broek MF; Spörri R; Even C; Plagemann PG; Hänseler E; Hengartner H; Zinkernagel RM J Immunol; 1997 Aug; 159(4):1585-8. PubMed ID: 9257815 [TBL] [Abstract][Full Text] [Related]
17. Chronic virus infection and immune responsiveness. II. Lactic dehydrogenase virus infection and immune response to non-viral antigens. Oldstone MB; Tishon A; Chiller JM J Immunol; 1974 Jan; 112(1):370-5. PubMed ID: 4590825 [No Abstract] [Full Text] [Related]
18. Acute cysticercosis favours rapid and more severe lesions caused by Leishmania major and Leishmania mexicana infection, a role for alternatively activated macrophages. Rodríguez-Sosa M; Rivera-Montoya I; Espinoza A; Romero-Grijalva M; López-Flores R; González J; Terrazas LI Cell Immunol; 2006 Aug; 242(2):61-71. PubMed ID: 17118349 [TBL] [Abstract][Full Text] [Related]
19. Ia antigens and Fc receptors of mouse peritoneal macrophages as determinants of susceptibility to lactic dehydrogenase virus. Inada T; Mims CA J Gen Virol; 1985 Jul; 66 ( Pt 7)():1469-77. PubMed ID: 3860626 [TBL] [Abstract][Full Text] [Related]
20. Antibody classes and subclasses in circulating immune complexes isolated from mice infected with lactic dehydrogenase virus. McDonald TL; Donnelly T; Weber A; Quenette L Immunology; 1983 Mar; 48(3):511-7. PubMed ID: 6826202 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]